These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9009235

  • 21. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line.
    Darnel AD, Archer TK, Yang K.
    J Steroid Biochem Mol Biol; 1999; 70(4-6):203-10. PubMed ID: 10622409
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Progesterone receptor transactivation of the secretory leukocyte protease inhibitor gene in Ishikawa endometrial epithelial cells involves recruitment of Krüppel-like factor 9/basic transcription element binding protein-1.
    Velarde MC, Iruthayanathan M, Eason RR, Zhang D, Simmen FA, Simmen RC.
    Endocrinology; 2006 Apr; 147(4):1969-78. PubMed ID: 16384861
    [Abstract] [Full Text] [Related]

  • 24. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
    Cho H, Aronica SM, Katzenellenbogen BS.
    Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Steroid hormones regulate the release of immunoreactive beta-endorphin from the Ishikawa human endometrial cell line.
    Makrigiannakis A, Margioris A, Markogiannakis E, Stournaras C, Gravanis A.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):584-9. PubMed ID: 1639959
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Sant'Anna GDS, Brum IS, Branchini G, Pizzolato LS, Capp E, Corleta HVE.
    Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
    Arnold JT, Lessey BA, Seppälä M, Kaufman DG.
    Cancer Res; 2002 Jan 01; 62(1):79-88. PubMed ID: 11782363
    [Abstract] [Full Text] [Related]

  • 32. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
    Wormke M, Castro-Rivera E, Chen I, Safe S.
    J Steroid Biochem Mol Biol; 2000 Apr 01; 72(5):197-207. PubMed ID: 10822009
    [Abstract] [Full Text] [Related]

  • 33. Basement membrane induced differentiation of HEC-1B(L) endometrial adenocarcinoma cells affects both morphology and gene expression.
    Hopfer H, Rinehart CA, Kaufman DG, Vollmer G.
    Biochem Cell Biol; 1996 Apr 01; 74(2):165-77. PubMed ID: 9213425
    [Abstract] [Full Text] [Related]

  • 34. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta).
    Slayden OD, Brenner RM.
    J Clin Endocrinol Metab; 1994 Feb 01; 78(2):440-8. PubMed ID: 8106633
    [Abstract] [Full Text] [Related]

  • 35. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
    Mirkin S, Archer DF.
    Contraception; 2004 Oct 01; 70(4):327-33. PubMed ID: 15451338
    [Abstract] [Full Text] [Related]

  • 36. Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa).
    Ørbo A, Moe BT, Grønaas H, Paulssen RH.
    J Steroid Biochem Mol Biol; 2009 Jan 01; 113(1-2):139-49. PubMed ID: 19138738
    [Abstract] [Full Text] [Related]

  • 37. [Responsiveness and mechanisms of action of steroid hormones in human endometrial adenocarcinoma cells].
    Hata H, Hata K, Hamano M, Shimoda T, Kuramoto H.
    Hum Cell; 1989 Sep 01; 2(3):265-71. PubMed ID: 2519214
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 39. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M, Schüler S, Lattrich C, Ignatov A, Ortmann O, Treeck O.
    Steroids; 2013 Nov 17; 78(11):1087-91. PubMed ID: 23921077
    [Abstract] [Full Text] [Related]

  • 40. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
    Neulen J, Williams RF, Breckwoldt M, Chwalisz K, Baulieu EE, Hodgen GD.
    Hum Reprod; 1996 Jul 17; 11(7):1533-7. PubMed ID: 8671500
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.